Akero Therapeutics Inc (AKRO)
43.74 x 1 46.72 x 1
Post-market by (Cboe BZX)
45.22 +0.56 (+1.25%) 03/21/25 [NASDAQ]
43.74 x 1 46.72 x 1
Post-market 45.22 unch (unch) 16:55 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | AKRO | RARE | CRSP | ||
| Company | Akero Therapeutics Inc | Ultragenyx Pharmaceu | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.28 | 38.53 | 40.71 | ||
| High | 45.92 | 39.28 | 41.68 | ||
| Low | 43.91 | 38.18 | 40.41 | ||
| Last | 45.22 | 39.18 | 41.22 | ||
| Change | +0.56 | +0.29 | +0.05 | ||
| % Change | +1.25% | +0.75% | +0.12% | ||
| Volume | 2,928,500 | 934,900 | 1,540,000 | ||
| 20-Day Average Volume | 984,230 | 753,860 | 1,641,685 | ||
| Previous Close | 44.66 | 38.89 | 41.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 45.29 | 40.10 | 43.14 | ||
| 20-Day Raw Stochastic | 36.90% | 32.30% | 11.29% | ||
| 20-Day Relative Strength | 52.16% | 42.96% | 45.37% | ||
| Weighted Alpha | -0.41 | -20.00 | -42.76 | ||
| Today's Opinion | 72% Buy | 100% Sell | 80% Sell | ||
| Previous Opinion | 72% Buy | 100% Sell | 80% Sell | ||
| Last Month's Opinion | 100% Buy | 32% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.42% since 03/14/25 | -0.41% since 03/14/25 | -2.14% since 03/14/25 | ||
| Low | 42.90 on 03/19/25 | 38.18 on 03/21/25 | 40.40 on 03/18/25 | ||
| High | 45.92 on 03/21/25 | 40.21 on 03/20/25 | 43.32 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | -12.77% since 02/21/25 | -8.01% since 02/21/25 | -13.96% since 02/21/25 | ||
| Low | 41.15 on 03/10/25 | 37.10 on 03/10/25 | 40.40 on 03/18/25 | ||
| High | 52.18 on 02/24/25 | 43.54 on 02/27/25 | 47.66 on 02/24/25 | ||
| 3-Month | |||||
| %Chg | +54.12% since 12/20/24 | -11.40% since 12/20/24 | +1.23% since 12/20/24 | ||
| Low | 21.34 on 01/14/25 | 37.10 on 03/10/25 | 36.52 on 01/13/25 | ||
| High | 58.40 on 01/27/25 | 46.50 on 02/06/25 | 55.88 on 02/19/25 | ||
| 6-Month | |||||
| %Chg | +61.04% since 09/20/24 | -33.31% since 09/20/24 | -14.45% since 09/20/24 | ||
| Low | 21.34 on 01/14/25 | 37.10 on 03/10/25 | 36.52 on 01/13/25 | ||
| High | 58.40 on 01/27/25 | 59.50 on 09/23/24 | 59.07 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,600,417 | 3,624,189 | 3,535,605 | ||
| Shares Outstanding, K | 79,620 | 92,501 | 85,774 | ||
| Annual Sales | 0 | 560,230,000 | 37,310,000 | ||
| Annual Net Income | -252,060,000 | -569,180,000 | -366,250,000 | ||
| Last Quarter Sales | 0 | 164,880,000 | 35,690,000 | ||
| Last Quarter Net Income | -70,020,000 | -133,390,000 | -37,310,000 | ||
| 60-Month Beta | -0.19 | 0.67 | 1.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 02/28/25 | -1.39 on 02/13/25 | -0.44 on 02/11/25 | ||
| Latest Earnings Date | 05/09/25 | 05/01/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||